Stockreport

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025 [Yahoo! Finance]

Elevation Oncology, Inc. - Common stock  (ELEV) 
PDF -- On-track to file an Investigational New Drug (IND) application in 2026 – BOSTON March 25, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovati [Read more]